308 related articles for article (PubMed ID: 26739214)
1. The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction.
Francis Stuart SD; De Jesus NM; Lindsey ML; Ripplinger CM
J Mol Cell Cardiol; 2016 Feb; 91():114-22. PubMed ID: 26739214
[TBL] [Abstract][Full Text] [Related]
2. The Janus face of myofibroblasts in the remodeling heart.
Hermans KC; Daskalopoulos EP; Blankesteijn WM
J Mol Cell Cardiol; 2016 Feb; 91():35-41. PubMed ID: 26690324
[No Abstract] [Full Text] [Related]
3. Systemic and Cardiac Depletion of M2 Macrophage through CSF-1R Signaling Inhibition Alters Cardiac Function Post Myocardial Infarction.
Leblond AL; Klinkert K; Martin K; Turner EC; Kumar AH; Browne T; Caplice NM
PLoS One; 2015; 10(9):e0137515. PubMed ID: 26407006
[TBL] [Abstract][Full Text] [Related]
4. Stem cell-related cardiac gene expression early after murine myocardial infarction.
Vandervelde S; van Luyn MJ; Rozenbaum MH; Petersen AH; Tio RA; Harmsen MC
Cardiovasc Res; 2007 Mar; 73(4):783-93. PubMed ID: 17208206
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin attenuates sympathetic hyperinnervation together with the augmentation of M2 macrophages in rats postmyocardial infarction.
Yang N; Cheng W; Hu H; Xue M; Li X; Wang Y; Xuan Y; Li X; Yin J; Shi Y; Yan S
Cardiovasc Ther; 2016 Aug; 34(4):234-44. PubMed ID: 27149420
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Fibrosis and Arrhythmogenesis.
Nguyen MN; Kiriazis H; Gao XM; Du XJ
Compr Physiol; 2017 Jun; 7(3):1009-1049. PubMed ID: 28640451
[TBL] [Abstract][Full Text] [Related]
7. The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction.
van Nieuwenhoven FA; Turner NA
Vascul Pharmacol; 2013 Mar; 58(3):182-8. PubMed ID: 22885638
[TBL] [Abstract][Full Text] [Related]
8. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.
Prabhu SD; Frangogiannis NG
Circ Res; 2016 Jun; 119(1):91-112. PubMed ID: 27340270
[TBL] [Abstract][Full Text] [Related]
9. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
10. Infiltrated cardiac lipids impair myofibroblast-induced healing of the myocardial scar post-myocardial infarction.
Vilahur G; Casani L; Juan-Babot O; Guerra JM; Badimon L
Atherosclerosis; 2012 Oct; 224(2):368-76. PubMed ID: 22882904
[TBL] [Abstract][Full Text] [Related]
11. Cardiomyocyte-specific overexpression of oestrogen receptor β improves survival and cardiac function after myocardial infarction in female and male mice.
Schuster I; Mahmoodzadeh S; Dworatzek E; Jaisser F; Messaoudi S; Morano I; Regitz-Zagrosek V
Clin Sci (Lond); 2016 Mar; 130(5):365-76. PubMed ID: 26608078
[TBL] [Abstract][Full Text] [Related]
12. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
[TBL] [Abstract][Full Text] [Related]
13. Mouse strain determines the outcome of wound healing after myocardial infarction.
van den Borne SW; van de Schans VA; Strzelecka AE; Vervoort-Peters HT; Lijnen PM; Cleutjens JP; Smits JF; Daemen MJ; Janssen BJ; Blankesteijn WM
Cardiovasc Res; 2009 Nov; 84(2):273-82. PubMed ID: 19542177
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and left ventricular remodelling after myocardial infarction.
Hori M; Nishida K
Cardiovasc Res; 2009 Feb; 81(3):457-64. PubMed ID: 19047340
[TBL] [Abstract][Full Text] [Related]
15. Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities.
Hilgendorf I; Frantz S; Frangogiannis NG
Circ Res; 2024 Jun; 134(12):1718-1751. PubMed ID: 38843294
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction.
Tillmanns J; Hoffmann D; Habbaba Y; Schmitto JD; Sedding D; Fraccarollo D; Galuppo P; Bauersachs J
J Mol Cell Cardiol; 2015 Oct; 87():194-203. PubMed ID: 26319660
[TBL] [Abstract][Full Text] [Related]
17. Up-regulated TLR4 in cardiomyocytes exacerbates heart failure after long-term myocardial infarction.
Liu L; Wang Y; Cao ZY; Wang MM; Liu XM; Gao T; Hu QK; Yuan WJ; Lin L
J Cell Mol Med; 2015 Dec; 19(12):2728-40. PubMed ID: 26290459
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin B2 receptor antagonism attenuates inflammation, mast cell infiltration and fibrosis in remote myocardium after infarction in rats.
Koike MK; de Carvalho Frimm C; de Lourdes Higuchi M
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1131-6. PubMed ID: 16445581
[TBL] [Abstract][Full Text] [Related]
19. The effector cells and cellular mediators of immune system involved in cardiac inflammation and fibrosis after myocardial infarction.
Liu Y; Xu J; Wu M; Kang L; Xu B
J Cell Physiol; 2020 Dec; 235(12):8996-9004. PubMed ID: 32352172
[TBL] [Abstract][Full Text] [Related]
20. TNFR gene-modified mesenchymal stem cells attenuate inflammation and cardiac dysfunction following MI.
Bao C; Guo J; Lin G; Hu M; Hu Z
Scand Cardiovasc J; 2008 Feb; 42(1):56-62. PubMed ID: 17852784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
